Cargando…
Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model
Traditional Chinese medicine (TCM) with the characteristics of “multi-component-multi-target-multi-pathway” has obvious advantages in the prevention and treatment of complex diseases, especially in the aspects of “treating the same disease with different treatments”. However, there are still some pr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365894/ https://www.ncbi.nlm.nih.gov/pubmed/32754034 http://dx.doi.org/10.3389/fphar.2020.01035 |
_version_ | 1783560118904815616 |
---|---|
author | Wang, Ke-xin Gao, Yao Lu, Cheng Li, Yao Zhou, Bo-ya Qin, Xue-mei Du, Guan-hua Gao, Li Guan, Dao-gang Lu, Ai-ping |
author_facet | Wang, Ke-xin Gao, Yao Lu, Cheng Li, Yao Zhou, Bo-ya Qin, Xue-mei Du, Guan-hua Gao, Li Guan, Dao-gang Lu, Ai-ping |
author_sort | Wang, Ke-xin |
collection | PubMed |
description | Traditional Chinese medicine (TCM) with the characteristics of “multi-component-multi-target-multi-pathway” has obvious advantages in the prevention and treatment of complex diseases, especially in the aspects of “treating the same disease with different treatments”. However, there are still some problems such as unclear substance basis and molecular mechanism of the effectiveness of formula. Network pharmacology is a new strategy based on system biology and poly-pharmacology, which could observe the intervention of drugs on disease networks at systematical and comprehensive level, and especially suitable for study of complex TCM systems. Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, causing articular and extra articular dysfunctions among patients, it could lead to irreversible joint damage or disability if left untreated. TCM formulas, Danggui-Sini-decoction (DSD), Guizhi-Fuzi-decoction (GFD), and Huangqi-Guizhi-Wuwu-Decoction (HGWD), et al., have been found successful in controlling RA in clinical applications. Here, a network pharmacology-based approach was established. With this model, key gene network motif with significant (KNMS) of three formulas were predicted, and the molecular mechanism of different formula in the treatment of rheumatoid arthritis (RA) was inferred based on these KNMSs. The results show that the KNMSs predicted by the model kept a high consistency with the corresponding C-T network in coverage of RA pathogenic genes, coverage of functional pathways and cumulative contribution of key nodes, which confirmed the reliability and accuracy of our proposed KNMS prediction strategy. All validated KNMSs of each RA therapy-related formula were employed to decode the mechanisms of different formulas treat the same disease. Finally, the key components in KNMSs of each formula were evaluated by in vitro experiments. Our proposed KNMS prediction and validation strategy provides methodological reference for interpreting the optimization of core components group and inference of molecular mechanism of formula in the treatment of complex diseases in TCM. |
format | Online Article Text |
id | pubmed-7365894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73658942020-08-03 Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model Wang, Ke-xin Gao, Yao Lu, Cheng Li, Yao Zhou, Bo-ya Qin, Xue-mei Du, Guan-hua Gao, Li Guan, Dao-gang Lu, Ai-ping Front Pharmacol Pharmacology Traditional Chinese medicine (TCM) with the characteristics of “multi-component-multi-target-multi-pathway” has obvious advantages in the prevention and treatment of complex diseases, especially in the aspects of “treating the same disease with different treatments”. However, there are still some problems such as unclear substance basis and molecular mechanism of the effectiveness of formula. Network pharmacology is a new strategy based on system biology and poly-pharmacology, which could observe the intervention of drugs on disease networks at systematical and comprehensive level, and especially suitable for study of complex TCM systems. Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, causing articular and extra articular dysfunctions among patients, it could lead to irreversible joint damage or disability if left untreated. TCM formulas, Danggui-Sini-decoction (DSD), Guizhi-Fuzi-decoction (GFD), and Huangqi-Guizhi-Wuwu-Decoction (HGWD), et al., have been found successful in controlling RA in clinical applications. Here, a network pharmacology-based approach was established. With this model, key gene network motif with significant (KNMS) of three formulas were predicted, and the molecular mechanism of different formula in the treatment of rheumatoid arthritis (RA) was inferred based on these KNMSs. The results show that the KNMSs predicted by the model kept a high consistency with the corresponding C-T network in coverage of RA pathogenic genes, coverage of functional pathways and cumulative contribution of key nodes, which confirmed the reliability and accuracy of our proposed KNMS prediction strategy. All validated KNMSs of each RA therapy-related formula were employed to decode the mechanisms of different formulas treat the same disease. Finally, the key components in KNMSs of each formula were evaluated by in vitro experiments. Our proposed KNMS prediction and validation strategy provides methodological reference for interpreting the optimization of core components group and inference of molecular mechanism of formula in the treatment of complex diseases in TCM. Frontiers Media S.A. 2020-07-10 /pmc/articles/PMC7365894/ /pubmed/32754034 http://dx.doi.org/10.3389/fphar.2020.01035 Text en Copyright © 2020 Wang, Gao, Lu, Li, Zhou, Qin, Du, Gao, Guan and Lu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wang, Ke-xin Gao, Yao Lu, Cheng Li, Yao Zhou, Bo-ya Qin, Xue-mei Du, Guan-hua Gao, Li Guan, Dao-gang Lu, Ai-ping Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model |
title | Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model |
title_full | Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model |
title_fullStr | Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model |
title_full_unstemmed | Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model |
title_short | Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model |
title_sort | uncovering the complexity mechanism of different formulas treatment for rheumatoid arthritis based on a novel network pharmacology model |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365894/ https://www.ncbi.nlm.nih.gov/pubmed/32754034 http://dx.doi.org/10.3389/fphar.2020.01035 |
work_keys_str_mv | AT wangkexin uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT gaoyao uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT lucheng uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT liyao uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT zhouboya uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT qinxuemei uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT duguanhua uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT gaoli uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT guandaogang uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel AT luaiping uncoveringthecomplexitymechanismofdifferentformulastreatmentforrheumatoidarthritisbasedonanovelnetworkpharmacologymodel |